Benchmark Holdings PLC Environmental recognition for CleanTreat(R)
23 September 2021 - 4:00PM
RNS Non-Regulatory
TIDMBMK
Benchmark Holdings PLC
23 September 2021
23 September 2021
Benchmark Holdings plc
("Benchmark" or the "Company")
Environmental recognition for CleanTreat (R)
Benchmark's CleanTreat (R) system receives highest recognition
for environmental protection
and sustainability from the Aquaculture Stewardship Council
Benchmark Holdings, the aquaculture biotechnology company, is
pleased to announce that the Aquaculture Stewardship Council (ASC),
the world's leading independent certification scheme for farmed
aquaculture, confirmed a score of 'zero' for its cutting-edge
CleanTreat(R) system. ASC plays a vital role in maintaining the
strictest environmental and welfare standards in the industry and
this is the highest level of recognition that it awards for
environmental protection and sustainability.
Following an extensive review, the ASC included CleanTreat(R) as
a mitigation tool in its current 'Weighted Number of Medicinal
Treatments'. ASC concluded that any treatments performed in a
closed contained system, that then applies water purification steps
to remove the veterinary medicine, will receive a score of 'zero' -
the best score possible.
This news represents a major milestone for Benchmark and is an
encouraging endorsement of its CleanTreat(R) system. An ASC scoring
of 'zero' for Benchmark's CleanTreat(R) system will support farmers
in meeting key ASC criteria, providing a valuable tool, which does
not increase the 'Weighted Number of Medicinal Treatments'.
Importantly, this allows farmers to use Integrated Pest Management
strategies, which are crucial to effective and robust sea lice
management. The effective use of Benchmark's CleanTreat(R) will
further enable the sustainable growth of the aquaculture industry
whilst protecting the surrounding environment.
CleanTreat(R) is a cutting-edge water purification system that
removes medicines from treatment water before safely returning
cleaned water to the sea. CleanTreat(R) also removes the organic
material from treatment water including sea lice, egg strings, fish
scales and faecal matter - an essential step in combating parasitic
resistance to medicines. Benchmark's Ectosan(R) Vet treatment,
launched in combination with CleanTreat(R), received Marketing
Authorisation from the Norwegian Medicines Agency in July 2021. The
Company's first CleanTreat(R) unit is currently in operation and
its Ectosan(R) Vet sea lice treatments were commenced for customers
during August 2021.
Trond Williksen, CEO, commented:
"Our mission is to drive sustainability in aquaculture and we
are delighted to have received the highest recognition possible by
the ASC for our CleanTreat(R) system. We are proud to help farmers
and the wider industry take a responsible approach to medicine use
and are excited to play a major role in driving sustainability
across the industry."
Enquiries:
For further information, please contact:
Benchmark Holdings plc Tel: 020 3696 0630
Trond Williksen, CEO
Septima Maguire, CFO
Ivonne Cantu, Investor Relations
Numis (Broker and NOMAD) Tel: 020 7260 1000
James Black, Freddie Barnfield, Duncan
Monteith
MHP Communications Tel: 020 3128 8742
Katie Hunt, Reg Hoare, Alistair de Kare-Silver
benchmark@mhpc.com
About Benchmark
Benchmark is a leading aquaculture biotechnology company.
Benchmark's mission is to enable aquaculture producers to improve
their sustainability and profitability.
We bring together biology and technology to develop innovative
products and solutions which improve yield, quality and animal
health and welfare for our customers. We do this by improving the
genetic make-up, health and nutrition of their stock - from
broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions,
including salmon eggs, live feed (Artemia), specialist diets and
probiotics and sea lice treatments. Find out more at
www.benchmarkplc.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEAPNAASSFEFA
(END) Dow Jones Newswires
September 23, 2021 02:00 ET (06:00 GMT)
Benchmark (LSE:BMK)
Historical Stock Chart
From Apr 2024 to May 2024
Benchmark (LSE:BMK)
Historical Stock Chart
From May 2023 to May 2024